Iopidine (Alcon Laboratories, Inc.)


Welcome to the PulseAid listing for the Iopidine drug offered from Alcon Laboratories, Inc.. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alcon Laboratories, Inc.
NON-PROPRIETARY NAME: apraclonidine
SUBSTANCE NAME: APRACLONIDINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1993-10-01
END MARKETING DATE: 0000-00-00


Iopidine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIopidine from Alcon Laboratories, Inc.
LABELER NAME: Alcon Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 1993-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0065-0665_77f2bac0-e03e-43ce-9af5-1a1d9b266b20
PRODUCT NDC: 0065-0665
APPLICATION NUMBER: NDA020258

Other APRACLONIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn Inc.Apraclonidine Ophthalmic
Alcon Laboratories, Inc.IOPIDINE
Sandoz Inc.Apraclonidine